START is dedicated to the conduct of Phase I Clinical Trials of novel anticancer agents.

With centers located in San Antonio, Grand Rapids, and Madrid, START conducts the world’s largest Phase I medical oncology program. Today, more than 50 percent of cancer patients can be cured with conventional treatments – that is, therapies with a proven response rate. However, there are many patients who do not respond to standard treatment and may be eligible for participation in our Phase I clinical trials program.

THE FACES OF START

Read Their Stories